Obesity-Related Atrial Fibrillation: Cardiac Manifestation of a Systemic Disease

Atrial fibrillation (AF) is the most common arrhythmia worldwide and is associated with increased morbidity and mortality. The mechanisms underlying AF are complex and multifactorial. Although it is well known that obesity is a strong risk factor for AF, the mechanisms underlying obesity-related AF are not completely understood. Current evidence proposes that in addition to overall hemodynamic changes due to increased body weight, excess adiposity raises systemic inflammation and oxidative stress, which lead to adverse atrial remodeling. This remodeling includes atrial fibrosis, atrial dilation, decreased electrical conduction between atrial myocytes, and altered ionic currents, making atrial tissue more vulnerable to both the initiation and maintenance of AF. However, much remains to be learned about the mechanistic links between obesity and AF. This knowledge will power the development of novel diagnostic tools and treatment options that will help combat the rise of the global AF burden among the obesity epidemic.

[1]  P. Noseworthy,et al.  Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures. , 2023, Journal of the American College of Cardiology.

[2]  E. Conte,et al.  Obesity and Cardiovascular Risk: Systematic Intervention Is the Key for Prevention , 2023, Healthcare.

[3]  Antônio da Silva Menezes Junior,et al.  Circulating MicroRNAs as Specific Biomarkers in Atrial Fibrillation: A Meta-Analysis , 2023, Non-coding RNA.

[4]  Huilei Zhao,et al.  Association between weight loss and outcomes in patients undergoing atrial fibrillation ablation: a systematic review and dose–response meta-analysis , 2023, Nutrition & Metabolism.

[5]  A. Rosengren,et al.  Body Mass Index in Adolescence and Long‐Term Risk of Early Incident Atrial Fibrillation and Subsequent Mortality, Heart Failure, and Ischemic Stroke , 2022, Journal of the American Heart Association.

[6]  W. Almahmeed,et al.  Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation. , 2022, European journal of preventive cardiology.

[7]  Ji-Zhong Shen,et al.  Comprehensive metabolomic characterization of atrial fibrillation , 2022, Frontiers in Cardiovascular Medicine.

[8]  S. Pan,et al.  The Risk of Atrial Fibrillation Increases with Earlier Onset of Obesity: A Mendelian Randomization Study , 2022, International journal of medical sciences.

[9]  M. Grabowski,et al.  Extracellular Vesicles in Atrial Fibrillation—State of the Art , 2022, International journal of molecular sciences.

[10]  A. Hajra,et al.  Current Advancement in Diagnosing Atrial Fibrillation by Utilizing Wearable Devices and Artificial Intelligence: A Review Study , 2022, Diagnostics.

[11]  R. Raffai,et al.  IL-4 polarized human macrophage exosomes control cardiometabolic inflammation & diabetes in obesity. , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  I. Kralj-Hans,et al.  Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis , 2022, Clinical Research in Cardiology.

[13]  C. Bursill,et al.  Associations between adipokines and atrial fibrillation: A systematic review and meta-analysis. , 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[14]  Weiqi Chen,et al.  Genetically predicted childhood obesity and adult atrial fibrillation: A mendelian randomization study. , 2021, NMCD. Nutrition Metabolism and Cardiovascular Diseases.

[15]  Congxin Huang,et al.  A narrative review of non-coding RNAs in atrial fibrillation: potential therapeutic targets and molecular mechanisms , 2021, Annals of translational medicine.

[16]  Chengming Fan,et al.  The Role of Exosomes and Their Cargos in the Mechanism, Diagnosis, and Treatment of Atrial Fibrillation , 2021, Frontiers in Cardiovascular Medicine.

[17]  T. Marwick,et al.  Prevention of Pathological Atrial Remodeling and Atrial Fibrillation: JACC State-of-the-Art Review. , 2021, Journal of the American College of Cardiology.

[18]  P. Ellinor,et al.  Genetic inhibition of serum glucocorticoid kinase 1 prevents obesity-related atrial fibrillation , 2021, bioRxiv.

[19]  Chiadi E. Ndumele,et al.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2021, Circulation.

[20]  M. Valderrábano,et al.  Sleep Apnea and Atrial Fibrillation: Role of the Cardiac Autonomic Nervous System. , 2021, Methodist DeBakey cardiovascular journal.

[21]  J. Leor,et al.  Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation , 2021, Circulation.

[22]  R. Mahajan,et al.  Atrial Fibrillation and Obesity: Reverse Remodeling of Atrial Substrate With Weight Reduction. , 2021, JACC. Clinical electrophysiology.

[23]  Y. Okumura,et al.  Effect of obesity and epicardial fat/fatty infiltration on electrical and structural remodeling associated with atrial fibrillation in a novel canine model of obesity and atrial fibrillation: A comparative study , 2021, Journal of cardiovascular electrophysiology.

[24]  Meng Wang,et al.  Association between Serum Adiponectin and Atrial Fibrillation: A Case-Control Study Stratified by Age and Gender , 2021, Cardiology research and practice.

[25]  P. Sanders,et al.  NLRP3 inflammasome is a key driver of Obesity-Induced atrial arrhythmias. , 2021, Cardiovascular research.

[26]  Yuhan Chen,et al.  Cadherin‐11 deficiency mitigates high‐fat diet‐induced inflammatory atrial remodeling and vulnerability to atrial fibrillation , 2021, Journal of cellular physiology.

[27]  Xianhui Zhou,et al.  Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway , 2020, Frontiers in Physiology.

[28]  Deping Liu,et al.  Inhibition of endoplasmic reticulum stress prevents high‐fat diet mediated atrial fibrosis and fibrillation , 2020, Journal of cellular and molecular medicine.

[29]  P. Sanders,et al.  Epicardial Adipose Tissue Accumulation Confers Atrial Conduction Abnormality. , 2020, Journal of the American College of Cardiology.

[30]  G. Gartlehner,et al.  The performance of anthropometric tools to determine obesity: a systematic review and meta-analysis , 2020, Scientific Reports.

[31]  I. Goldenberg,et al.  Predictors of Atrial Fibrillation During Long‐Term Implantable Cardiac Monitoring Following Cryptogenic Stroke , 2020, Journal of the American Heart Association.

[32]  S. Nattel,et al.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy , 2020, Circulation research.

[33]  Xun Ai,et al.  Ion Channel and Structural Remodeling in Obesity-Mediated Atrial Fibrillation , 2020, Circulation. Arrhythmia and electrophysiology.

[34]  A. Farshid,et al.  Adherence to guidelines regarding anticoagulation and risk factors for progression of atrial fibrillation in a nurse‐led clinic , 2020, Internal medicine journal.

[35]  A. Bogers,et al.  Heterogeneity in Conduction Underlies Obesity-Related Atrial Fibrillation Vulnerability , 2020, Circulation. Arrhythmia and electrophysiology.

[36]  A. Chait,et al.  Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease , 2020, Frontiers in Cardiovascular Medicine.

[37]  F. Hu,et al.  Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity , 2020, Nature Reviews Endocrinology.

[38]  Gretchen A. Stevens,et al.  The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action , 2019, BMC Medicine.

[39]  J. Plaza-Díaz,et al.  Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases , 2019, International journal of molecular sciences.

[40]  P. Schauer,et al.  Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[41]  E. Socha,et al.  High leptin and low blood adiponectin, TNF-alpha and irisin blood concentrations as factors linking obesity with the risk of atrial fibrillation among inpatients with cardiovascular disorders. , 2019, Kardiologia polska.

[42]  L. Martinez-Mateu,et al.  Differential Modulation of IK and ICa,L Channels in High-Fat Diet-Induced Obese Guinea Pig Atria , 2019, Front. Physiol..

[43]  Yan V. Sun,et al.  Serum Metabolomics and Incidence of Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study). , 2019, The American journal of cardiology.

[44]  S. Larsson,et al.  Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study , 2019, European heart journal.

[45]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[46]  He Huang,et al.  MD1 Deficiency Promotes Inflammatory Atrial Remodelling Induced by High-Fat Diets. , 2019, The Canadian journal of cardiology.

[47]  Christopher X. Wong,et al.  Electroanatomical Remodeling of the Atria in Obesity: Impact of Adjacent Epicardial Fat. , 2018, JACC. Clinical electrophysiology.

[48]  Qiang Xu,et al.  Apelin: A novel prognostic predictor for atrial fibrillation recurrence after pulmonary vein isolation , 2018, Medicine.

[49]  L. Chen,et al.  Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status: ARIC Study (Atherosclerosis Risk in Communities) , 2018, Circulation. Arrhythmia and electrophysiology.

[50]  R. Mahajan,et al.  PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[51]  L. Ngo,et al.  Left Atrial Epicardial Fat Volume Is Associated With Atrial Fibrillation: A Prospective Cardiovascular Magnetic Resonance 3D Dixon Study , 2018, Journal of the American Heart Association.

[52]  L. Sobrevia,et al.  Extracellular vesicles in obesity and diabetes mellitus. , 2017, Molecular aspects of medicine.

[53]  Jong Bae Seo,et al.  Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity , 2017, Cell.

[54]  T. Chao,et al.  Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation: A Report From the Taiwan Nationwide AF Cohort Study , 2017, Chest.

[55]  F. Akar,et al.  Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes , 2017, Cardiovascular Diabetology.

[56]  U. Schotten,et al.  Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats , 2017, Journal of the American Heart Association.

[57]  Alexander S. Banks,et al.  Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes. , 2017, The Journal of clinical investigation.

[58]  V. Melenovský,et al.  Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction , 2017, Circulation.

[59]  John P H Wilding,et al.  Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation , 2017, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[60]  M. Zaki,et al.  Serum apelin levels and metabolic risk markers in obese women , 2017, Journal, genetic engineering & biotechnology.

[61]  T. Masaki,et al.  Hyperleptinemia Exacerbates High‐Fat Diet‐Mediated Atrial Fibrosis and Fibrillation , 2017, Journal of cardiovascular electrophysiology.

[62]  H. Kennedy,et al.  Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact , 2017, Clinical cardiology.

[63]  Huishan Wang,et al.  Relationship between Angiotensin Converting Enzyme, Apelin, and New-Onset Atrial Fibrillation after Off-Pump Coronary Artery Bypass Grafting , 2017, BioMed Research International.

[64]  C. Kahn,et al.  Adipose-Derived Circulating miRNAs Regulate Gene Expression in Other Tissues , 2017, Nature.

[65]  Christopher X. Wong,et al.  Associations of Epicardial, Abdominal, and Overall Adiposity With Atrial Fibrillation , 2016, Circulation. Arrhythmia and electrophysiology.

[66]  K. Lunetta,et al.  Genetic Obesity and the Risk of Atrial Fibrillation: Causal Estimates from Mendelian Randomization. , 2016, Circulation.

[67]  J. Kirwan,et al.  Brown and Beige Adipose Tissue: Therapy for Obesity and Its Comorbidities? , 2016, Endocrinology and metabolism clinics of North America.

[68]  S. Andreadis,et al.  Cadherin-11 is a novel regulator of extracellular matrix synthesis and tissue mechanics , 2016, Journal of Cell Science.

[69]  D. Kass,et al.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap , 2016, Circulation.

[70]  Christopher X. Wong,et al.  Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions , 2016, European heart journal.

[71]  A. Jahangir,et al.  Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation , 2016, Cardiology in review.

[72]  Fan Zhang,et al.  High fat diet induced alterations of atrial electrical activities in mice. , 2016, American journal of cardiovascular disease.

[73]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[74]  Wenjun Xie,et al.  Mitochondrial oxidative stress promotes atrial fibrillation , 2015, Scientific Reports.

[75]  Rajiv Mahajan,et al.  Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity. , 2015, Journal of the American College of Cardiology.

[76]  Y. Okumura,et al.  Effects of a high-fat diet on the electrical properties of porcine atria , 2015, Journal of arrhythmia.

[77]  Christopher X. Wong,et al.  Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation: A Meta-Analysis of 626,603 Individuals in 51 Studies. , 2015, JACC. Clinical electrophysiology.

[78]  Christopher X. Wong,et al.  Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). , 2015, Journal of the American College of Cardiology.

[79]  J. Garvey,et al.  Epidemiological aspects of obstructive sleep apnea. , 2015, Journal of thoracic disease.

[80]  B. Psaty,et al.  Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults , 2015, Heart.

[81]  Monica Jeanne Hubal,et al.  Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease. , 2014, The Journal of surgical research.

[82]  C. Théry,et al.  Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.

[83]  Paulus Kirchhof,et al.  Quality of life in patients with atrial fibrillation: how to assess it and how to improve it. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[84]  C. Fox,et al.  Pericardial Fat is Associated With Atrial Conduction: The Framingham Heart Study , 2014, Journal of the American Heart Association.

[85]  David G Strauss,et al.  Infiltrated atrial fat characterizes underlying atrial fibrillation substrate in patients at risk as defined by the ARIC atrial fibrillation risk score. , 2014, International journal of cardiology.

[86]  W. Abhayaratna,et al.  Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. , 2013, JAMA.

[87]  D. Singer,et al.  Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. , 2013, The American journal of cardiology.

[88]  Simon Stewart,et al.  Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. , 2013, International journal of cardiology.

[89]  S. Takanashi,et al.  Epicardial Adipose Tissue Volume and Adipocytokine Imbalance Are Strongly Linked to Human Coronary Atherosclerosis , 2022 .

[90]  José Jalife,et al.  Rotors and the Dynamics of Cardiac Fibrillation , 2013, Circulation research.

[91]  N. Estes,et al.  The Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex Interplay , 2013, Pulmonary medicine.

[92]  M. Fasshauer,et al.  Effects of Weight Loss and Exercise on Apelin Serum Concentrations and Adipose Tissue Expression in Human Obesity , 2013, Obesity Facts.

[93]  D. Sánchez-Quintana,et al.  Send Orders of Reprints at Reprints@benthamscience.org Triggers and Anatomical Substrates in the Genesis and Perpetuation of Atrial Fibrillation , 2022 .

[94]  B. Antuna-Puente,et al.  Adiponectin: anti-inflammatory and cardioprotective effects. , 2012, Biochimie.

[95]  Wenjun Xie,et al.  Calcium Leak Through Ryanodine Receptors Leads to Atrial Fibrillation in 3 Mouse Models of Catecholaminergic Polymorphic Ventricular Tachycardia , 2012, Circulation research.

[96]  S. Bielinski,et al.  Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[97]  C. Bilato,et al.  Atrial Fibrillation Associated with Heart Failure, Stroke and Mortality. , 2012, Journal of atrial fibrillation.

[98]  P. Platonov,et al.  Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. , 2011, Journal of the American College of Cardiology.

[99]  P. Scherer,et al.  Adipose tissue remodeling and obesity. , 2011, The Journal of clinical investigation.

[100]  S. Johnston,et al.  Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States , 2011, Circulation. Cardiovascular quality and outcomes.

[101]  A. Curtis,et al.  Relation of obesity to recurrence rate and burden of atrial fibrillation. , 2011, The American journal of cardiology.

[102]  K. Clarke,et al.  A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart , 2011, Basic Research in Cardiology.

[103]  Udo Hoffmann,et al.  Pericardial Fat Is Associated With Prevalent Atrial Fibrillation: The Framingham Heart Study , 2010, Circulation. Arrhythmia and electrophysiology.

[104]  A. D'Angelo,et al.  Apelin Plasma Levels Predict Arrhythmia Recurrence in Patients with Persistent Atrial Fibrillation , 2010, International journal of immunopathology and pharmacology.

[105]  J. Manson,et al.  The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). , 2010, Journal of the American College of Cardiology.

[106]  H. Calkins,et al.  A Prospective Study Evaluating the Role of Obesity and Obstructive Sleep Apnea for Outcomes After Catheter Ablation of Atrial Fibrillation , 2010, Journal of cardiovascular electrophysiology.

[107]  M. Ibrahim Subcutaneous and visceral adipose tissue: structural and functional differences , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[108]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, Lancet.

[109]  J. Seward,et al.  Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. , 2008, European heart journal.

[110]  K. Reynolds,et al.  Global burden of obesity in 2005 and projections to 2030 , 2008, International Journal of Obesity.

[111]  G. Lamas,et al.  Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective , 2008, Journal of medical economics.

[112]  M. Drent,et al.  The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[113]  Thomas D. Giles,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[114]  K. Clarke,et al.  Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels. , 2005, Diabetes.

[115]  Anoop Misra,et al.  Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. , 2005, Nutrition.

[116]  Stanley Nattel,et al.  Mechanisms of atrial fibrillation: lessons from animal models. , 2005, Progress in cardiovascular diseases.

[117]  Paul A Friedman,et al.  Association of Atrial Fibrillation and Obstructive Sleep Apnea , 2004, Circulation.

[118]  J. McMurray,et al.  Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK , 2004, Heart.

[119]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[120]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[121]  Stanley Nattel,et al.  Cellular electrophysiology of atrial fibrillation. , 2002, Cardiovascular research.

[122]  David Amar,et al.  Older Age Is the Strongest Predictor of Postoperative Atrial Fibrillation , 2002, Anesthesiology.

[123]  P. Arner Catecholamine-induced lipolysis in obesity , 1999, International Journal of Obesity.

[124]  Harry L. Smith,et al.  ADIPOSITY OF THE HEART: A CLINICAL AND PATHOLOGIC STUDY OF ONE HUNDRED AND THIRTY-SIX OBESE PATIENTS , 1933 .

[125]  M. Peller,et al.  Are adipokines associated with atrial fibrillation in type 2 diabetes? , 2020, Endokrynologia Polska.

[126]  Z. Bartuzi,et al.  Leptin, adiponectin, tumor necrosis factor α, and irisin concentrations as factors linking obesity with the risk of atrial fibrillation among inpatients with cardiovascular diseases , 2019 .

[127]  P. Leprince,et al.  Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria , 2017, European heart journal.

[128]  Yuan Zhang,et al.  Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. , 2013, Heart rhythm.

[129]  C. Folmes,et al.  Myocardial fatty acid metabolism in health and disease. , 2010, Physiological reviews.

[130]  S Nattel,et al.  Of circles and spirals: bridging the gap between the leading circle and spiral wave concepts of cardiac reentry. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[131]  D. Parish,et al.  Obesity and the risk of new-onset atrial fibrillation. , 2005, JAMA.